- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.K. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
AstraZeneca
Market Cap: UK£167.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£111.58
7D
7.8%
1Y
-8.6%
GSK
Market Cap: UK£56.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£13.97
7D
3.7%
1Y
-9.4%